The chemical substance known as (E)-8-[2-[4-(4-Phenylbutoxy)phenyl]vinyl]-2-(1H-tetrazol-5-yl)-4H-benzopyran-4-one, with the CAS number 197506-02-8, is a synthetic organic compound characterized by its complex structure, which includes a benzopyran core, a tetrazole moiety, and a phenylbutoxy substituent. This compound exhibits properties typical of benzopyran derivatives, such as potential antioxidant and anti-inflammatory activities. The presence of the tetrazole ring may contribute to its biological activity, as tetrazoles are known to interact with various biological targets. The (E)-configuration indicates a specific geometric arrangement around the double bond, which can influence the compound's reactivity and interaction with biological systems. Additionally, the presence of multiple aromatic rings suggests potential for π-π stacking interactions, which can be relevant in drug design and molecular recognition processes. Overall, this compound's unique structural features may make it of interest in medicinal chemistry and pharmacological research.

(E)-8-[2-[4-(4-Phenylbutoxy)phenyl]vinyl]-2-(1H-tetrazol-5-yl)-4H-benzopyran-4-one

197506-02-8: The chemical substance known as (E)-8-[2-[4-(4-Phenylbutoxy)phenyl]vinyl]-2-(1H-tetrazol-5-yl)-4H-benzopyran-4-one, with the CAS number 197506-02-8, is a synthetic organic compound characterized by its complex structure, which includes a benzopyran core, a tetrazole moiety, and a phenylbutoxy substituent. This compound exhibits properties typical of benzopyran derivatives, such as potential antioxidant and anti-inflammatory activities. The presence of the tetrazole ring may contribute to its biological activity, as tetrazoles are known to interact with various biological targets. The (E)-configuration indicates a specific geometric arrangement around the double bond, which can influence the compound's reactivity and interaction with biological systems. Additionally, the presence of multiple aromatic rings suggests potential for π-π stacking interactions, which can be relevant in drug design and molecular recognition processes. Overall, this compound's unique structural features may make it of interest in medicinal chemistry and pharmacological research.

<p>LM-1484 is a protein that has been shown to induce apoptosis in human cancer cells. This potent anticancer agent is an analog of cyclin-dependent kinase inhibitors and works by inhibiting kinases involved in tumor growth. LM-1484 has been found in the urine of Chinese patients with cancer, suggesting its potential as a biomarker for early detection of cancer. Its ability to selectively target cancer cells without affecting healthy cells makes it a promising candidate for future cancer therapies.</p>

LM-1484

LM-1484 displays a higher affinity for 3H-LTC4 sites and is an antagonist of CysLT1 receptor.

CAS 197506-02-8

(E)-8-[2-[4-(4-Phenylbutoxy)phenyl]vinyl]-2-(1H-tetrazol-5-yl)-4H-benzopyran-4-one

LM-1484

Ref: 3D-XHA50602

LM-1484

Ref: TM-T11860